Literature DB >> 16133454

Detection and differentiation of lactate and lipids by single-voxel proton MR spectroscopy.

Fumiyuki Yamasaki1, Junko Takaba, Megu Ohtaki, Nobukazu Abe, Yoshinori Kajiwara, Taiichi Saito, Hiroyuki Yoshioka, Seiji Hama, Tomohide Akimitsu, Kazuhiko Sugiyama, Kazunori Arita, Kaoru Kurisu.   

Abstract

The signals of lactate and lipids partially overlap in single-voxel proton MR spectroscopy (1HMRS), sometimes making them difficult to differentiate in clinical settings. Our aim in this study was to identify lactate and lipids by varying the echo time (TE). We expect that the accurate detection of lactate and lipids will have high diagnostic value in the diagnosis of brain tumors. Following our protocol, we obtained meaningful 1HMRS spectra from 213 patients, including 163 patients with brain tumors, between August 1999 and February 2004. 1HMRS was performed with a TE of 144 ms followed by a TE of 30 ms and/or a TE of 288 ms, if necessary. For the 213 patients, lactate level was "negative" in 47 patients, "positive" in 131 patients, and "strongly positive" in 35 patients. The lipid level was "negative" in 90 patients, "positive" in 56 patients, and "strongly positive" in 67 patients. Based on logistic discriminant analyses of neuro-epithelial tumor WHO grade and lactate and lipid levels, lactate and lipid levels were significant between WHO grades 2 and 3 (P=0.0239) and between grades 3 and 4 (P=0.0347). Lipids are a more significant factor for the discrimination between WHO grades 2 and 3 (P=0.0073) and between grades 3 and 4 (P=0.0048). With our method of varying the TE, it is possible accurately and efficiently to detect lactate and lipids in the brain. We found a significant correlation between lactate and lipid expression and WHO grade of neuro-epithelial tumors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16133454     DOI: 10.1007/s10143-005-0398-1

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN: 0344-5607            Impact factor:   3.042


  35 in total

1.  Proton MR spectroscopy in Wernicke encephalopathy.

Authors:  Carlos A Rugilo; Marcela C Uribe Roca; Maria C Zurru; Arístides A Capizzano; Gustavo A Pontello; Emilia M Gatto
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

2.  Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.

Authors:  P M Matthews; G Francis; J Antel; D L Arnold
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

3.  In vivo single-voxel proton MR spectroscopy in intracranial cystic masses.

Authors:  K H Chang; I C Song; S H Kim; M H Han; H D Kim; S O Seong; H W Jung; M C Han
Journal:  AJNR Am J Neuroradiol       Date:  1998-03       Impact factor: 3.825

4.  Human brain infarction: proton MR spectroscopy.

Authors:  J H Duijn; G B Matson; A A Maudsley; J W Hugg; M W Weiner
Journal:  Radiology       Date:  1992-06       Impact factor: 11.105

5.  Brain tumor classification by proton MR spectroscopy: comparison of diagnostic accuracy at short and long TE.

Authors:  Carles Majós; Margarida Julià-Sapé; Juli Alonso; Marta Serrallonga; Carles Aguilera; Juan J Acebes; Carles Arús; Jaume Gili
Journal:  AJNR Am J Neuroradiol       Date:  2004 Nov-Dec       Impact factor: 3.825

6.  Proton MR spectroscopy and diffusion-weighted MR imaging for the diagnosis of intracranial tuberculomas. Report of two cases.

Authors:  Makio Kaminogo; Hideki Ishimaru; Minoru Morikawa; Yaeko Suzuki; Shobu Shibata
Journal:  Neurol Res       Date:  2002-09       Impact factor: 2.448

7.  Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging.

Authors:  Ping H Lai; Jih T Ho; Wei L Chen; Shu S Hsu; Jyh S Wang; Huay B Pan; Chien F Yang
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

8.  Localized proton MR spectroscopy of the brain in children.

Authors:  A A Tzika; D B Vigneron; W S Ball; R S Dunn; D R Kirks
Journal:  J Magn Reson Imaging       Date:  1993 Sep-Oct       Impact factor: 4.813

9.  Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy.

Authors:  F A Howe; S J Barton; S A Cudlip; M Stubbs; D E Saunders; M Murphy; P Wilkins; K S Opstad; V L Doyle; M A McLean; B A Bell; J R Griffiths
Journal:  Magn Reson Med       Date:  2003-02       Impact factor: 4.668

10.  Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy.

Authors:  A Aria Tzika; Leo Ling Cheng; Liliana Goumnerova; Joseph R Madsen; David Zurakowski; Loukas G Astrakas; Maria K Zarifi; R Michael Scott; Douglas C Anthony; R Gilberto Gonzalez; Peter McL Black
Journal:  J Neurosurg       Date:  2002-06       Impact factor: 5.115

View more
  10 in total

Review 1.  Metabolomic signature of brain cancer.

Authors:  Renu Pandey; Laura Caflisch; Alessia Lodi; Andrew J Brenner; Stefano Tiziani
Journal:  Mol Carcinog       Date:  2017-07-17       Impact factor: 4.784

Review 2.  Clinical Applications of Magnetic Resonance Spectroscopy in Brain Tumors: From Diagnosis to Treatment.

Authors:  Brent D Weinberg; Manohar Kuruva; Hyunsuk Shim; Mark E Mullins
Journal:  Radiol Clin North Am       Date:  2021-03-23       Impact factor: 2.303

3.  OKN-007 decreases tumor necrosis and tumor cell proliferation and increases apoptosis in a preclinical F98 rat glioma model.

Authors:  Patricia Coutinho de Souza; Krithika Balasubramanian; Charity Njoku; Natalyia Smith; David L Gillespie; Andrea Schwager; Osama Abdullah; Jerry W Ritchey; Kar-Ming Fung; Debra Saunders; Randy L Jensen; Rheal A Towner
Journal:  J Magn Reson Imaging       Date:  2015-04-29       Impact factor: 4.813

4.  Magnetic resonance spectroscopic detection of lactate is predictive of a poor prognosis in patients with diffuse intrinsic pontine glioma.

Authors:  Fumiyuki Yamasaki; Kaoru Kurisu; Yoshinori Kajiwara; Yosuke Watanabe; Takeshi Takayasu; Yuji Akiyama; Taiichi Saito; Ryosuke Hanaya; Kazuhiko Sugiyama
Journal:  Neuro Oncol       Date:  2011-06-08       Impact factor: 12.300

5.  Contribution of NMR spectroscopy to the differential diagnosis of a recurrent cranial mass 7 years after irradiation for a pediatric ependymoma.

Authors:  Isabelle Rutten; Daniel Raket; Nadine Francotte; Pierre Philippet; Shih-Li Chao; Marc Lemort
Journal:  Childs Nerv Syst       Date:  2006-05-18       Impact factor: 1.475

6.  Amide proton transfer-weighted MRI can detect tissue acidosis and monitor recovery in a transient middle cerebral artery occlusion model compared with a permanent occlusion model in rats.

Authors:  Ji Eun Park; Seung Chai Jung; Ho Sung Kim; Ji-Yeon Suh; Jin Hee Baek; Chul-Woong Woo; Bumwoo Park; Dong-Cheol Woo
Journal:  Eur Radiol       Date:  2019-01-21       Impact factor: 5.315

7.  Magnetic resonance spectroscopy for the study of cns malignancies.

Authors:  Victor Ruiz-Rodado; Jeffery R Brender; Murali K Cherukuri; Mark R Gilbert; Mioara Larion
Journal:  Prog Nucl Magn Reson Spectrosc       Date:  2020-12-02       Impact factor: 9.795

Review 8.  Applying metabolomics to understand the aggressive phenotype and identify novel therapeutic targets in glioblastoma.

Authors:  Kamran A Ahmed; Prakash Chinnaiyan
Journal:  Metabolites       Date:  2014-08-27

Review 9.  Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas.

Authors:  Patrick-Denis St-Coeur; Mohamed Touaibia; Miroslava Cuperlovic-Culf; Pier Morin
Journal:  Genomics Proteomics Bioinformatics       Date:  2013-06-01       Impact factor: 7.691

10.  Advanced magnetic resonance imaging findings of cerebellar hemangioblastomas: A report of three cases and a literature review.

Authors:  Eiji Matsusue; Chie Inoue; Sadaharu Tabuchi; Hiroki Yoshioka; Yuichiro Nagao; Kensuke Matsumoto; Kazuhiko Nakamura; Shinya Fujii
Journal:  Acta Radiol Open       Date:  2022-03-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.